DNAH10 mutation correlates with cisplatin sensitivity and tumor mutation burden in small-cell lung cancer

Chemotherapies based on platinum have been the standard first-line treatment for patients with small-cell lung cancer(SCLC) in the past years. However, the progression of patients occurs mostly due to rapid development of resistance to chemotherapy. In addition, the mechanisms involved in developmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Man, Lin, Anqi, Luo, Peng, Shen, Weitao, Xiao, Dan, Gou, Lanying, Zhang, Jian, Guo, Linlang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053592/
https://www.ncbi.nlm.nih.gov/pubmed/31959735
http://dx.doi.org/10.18632/aging.102683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053592/
https://www.ncbi.nlm.nih.gov/pubmed/31959735
http://dx.doi.org/10.18632/aging.102683

Ejemplares similares